GILEAD SCIENCES INC (GILD)       84  +0.06 (+0.07%)

84  +0.06 (+0.07%)

US3755581036 - Common Stock - Premarket: 83.6 -0.4 (-0.48%)

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
22.449B
1.46%
24.689B
9.98%
27.305B
10.60%
27.025B
-1.03%
EBITDA
13.29B
0.14%
13.032B
-1.94%
15.543B
19.27%
13.648B
-12.19%
N/AN/AN/AN/A
EBIT
4.459B
-46.74%
4.071B
-8.70%
9.918B
143.63%
12.307B
24.09%
Operating Margin
19.86%16.49%36.32%45.54%
EPS
7.16
1.40%
7.20
0.49%
8.32
15.66%
7.25
-12.85%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS1.45
-18.50%
1.52
-6.12%
Revenue6.246B
-15.83%
6.774B
-6.49%
EBITDA3.01B
-20.37%
2.769B
-21.29%
N/AN/AN/AN/A
EBIT2.837B
-26.16%
2.655B
182.45%
N/AN/AN/AN/A

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 1.90 1.45 0.4530.66% Q2 2022 1.58 1.55 0.032.16% Q1 2022 2.12 1.84 0.2815.00% Q4 2021 0.69 1.62 -0.93-57.52% Q3 2021 2.65 1.78 0.8748.53% Q2 2021 1.87 1.77 0.105.70% Q1 2021 2.08 2.13 -0.05-2.39% Q4 2020 2.19 2.19 0.00-0.14%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 7.042B 6.246B 796M12.74% Q2 2022 6.26B 5.969B 291M4.88% Q1 2022 6.59B 6.401B 189M2.95% Q4 2021 7.244B 6.793B 451M6.64% Q3 2021 7.421B 6.403B 1.018B15.90% Q2 2021 6.217B 6.192B 25M0.40% Q1 2021 6.423B 6.88B -457M-6.64% Q4 2020 7.421B 7.475B -54M-0.72%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPS0.5% 2.86% 0% 7.8%
Revenue-0.15% 1.2% 0% 1.41%